Decision making in clinical trials: Interim analyses, innovative design, and biomarkers.
Saved in:
| Title: | Decision making in clinical trials: Interim analyses, innovative design, and biomarkers. |
|---|---|
| Authors: | Welsh-Bohmer KA; Department of Psychiatry & Neurology Duke University Durham North Carolina USA., Kerchner GA; Pharma Research and Early Development F. Hoffmann-La Roche, Ltd Basel Switzerland., Dhadda S; Eisai Inc. Nutley New Jersey USA., Garcia M; Boehringer Ingelheim Pharmaceuticals Inc. Ridgefield Connecticut USA., Miller DS; Signant Health Blue Bell Pennsylvania USA., Natanegara F; Eli Lilly and Company Lilly Corporate Center Indianapolis Indiana USA., Raket LL; Novo Nordisk A/S Søborg Denmark., Robieson W; AbbVie North Chicago Illinois USA., Siemers ER; ACUMEN Pharmaceuticals Charlottesville Virginia USA., Carrillo MC; Alzheimer's Association Chicago Illinois USA., Weber CJ; Alzheimer's Association Chicago Illinois USA. |
| Source: | Alzheimer's & dementia (New York, N. Y.) [Alzheimers Dement (N Y)] 2023 Oct 18; Vol. 9 (4), pp. e12421. Date of Electronic Publication: 2023 Oct 18 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley on behalf of the Alzheimer's Association Country of Publication: United States NLM ID: 101650118 Publication Model: eCollection Cited Medium: Internet ISSN: 2352-8737 (Electronic) Linking ISSN: 23528737 NLM ISO Abbreviation: Alzheimers Dement (N Y) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2352-8737 |
|---|---|
| DOI: | 10.1002/trc2.12421 |
